Clinical decision support encouraged appropriate CKD screening, diagnosis, and antihypertensive therapy.<h4>Main outcomes and measures</h4>The primary outcome was change in SBP in individuals with APOL1 high-risk allelles at 3 months, assessed in a modified intention-to-treat analysis. The gene discussed is APOL1; the disease is chronic kidney disease.